Endovascular Abdominal Aortic Aneurysm Repair by Interventional Cardiologists (EVAR)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Abhijeet Basoor, St. Joseph Mercy Oakland Hospital
ClinicalTrials.gov Identifier:
NCT01452620
First received: October 12, 2011
Last updated: October 14, 2011
Last verified: October 2011
  Purpose

Registry for Endovascular repair of abdominal aortic aneurysm performed primarily by Interventional Cardiologists


Condition
Endovascular Abdominal Aortic Aneurysm Repair (EVAR)

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective

Resource links provided by NLM:


Further study details as provided by St. Joseph Mercy Oakland Hospital:

Primary Outcome Measures:
  • Mortality [ Time Frame: mean follow up, 30 months ] [ Designated as safety issue: Yes ]

Secondary Outcome Measures:
  • Complications [ Time Frame: mean follow up, 30 months ] [ Designated as safety issue: Yes ]
    Peri-procedural (30 day) and follow up complications


Enrollment: 170
Study Start Date: January 2011
Study Completion Date: May 2011
Primary Completion Date: May 2011 (Final data collection date for primary outcome measure)
Groups/Cohorts
EVAR cohort
All consecutive patients undergoing endovascular AAA repair (EVAR) in our community setting were followed for outcomes.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Study patients comprised of all patients undergoing endovascular abdominal aortic aneurysm repair performed primarily by Interventional Cardiologists in our community setting.

Criteria

Inclusion Criteria:

  • Patients with abdominal aortic aneurysm amenable for endovascular repair

Exclusion Criteria:

  • Pregnant patients
  • Patients less than 18 years old.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01452620

Locations
United States, Michigan
St. Joseph Mercy Oakland Hospital
Pontiac, Michigan, United States, 48341
Sponsors and Collaborators
St. Joseph Mercy Oakland Hospital
Investigators
Principal Investigator: Abhijeet Basoor, MD St. Joseph Mercy Oakland Hospital
Study Director: Kiritkumar Patel, MD St. Joseph Mercy Oakland Hospital
Study Director: Abdul R Halabi, MD St. Joseph Mercy Oakland Hospital
Study Director: Nishit Choksi, MD St. Joseph Mercy Oakland Hospital
Study Director: Thanh Phan, MD St. Joseph Mercy Oakland Hospital
Study Director: Michele DeGregorio, MD St. Joseph Mercy Oakland Hospital
  More Information

No publications provided

Responsible Party: Abhijeet Basoor, MD, St. Joseph Mercy Oakland Hospital
ClinicalTrials.gov Identifier: NCT01452620     History of Changes
Other Study ID Numbers: 11-10-01
Study First Received: October 12, 2011
Last Updated: October 14, 2011
Health Authority: United States: Institutional Review Board

Keywords provided by St. Joseph Mercy Oakland Hospital:
Endovascular Abdominal Aortic Aneurysm Repair (EVAR)
Abdominal Aortic aneurysm (AAA)

Additional relevant MeSH terms:
Aneurysm
Aortic Aneurysm
Aortic Aneurysm, Abdominal
Vascular Diseases
Cardiovascular Diseases
Aortic Diseases

ClinicalTrials.gov processed this record on August 01, 2014